Usiminas Sa ADR Regs (USNZY) 1.0200 $USNZY LB F
Post# of 273254
LB Foster's Exposure to Price Fluctuations Raises Concerns
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 9:27AM CDT
On Jun 7, 2016, we issued an updated research report on premium railroads manufacturing firm LB Foster Co. (FSTR).
FSTR: 11.71 (+0.54), ZEUS: 19.48 (-0.04), MT: 5.56 (+0.11)
ArcelorMittal Sells 35% Stake in Gestamp to Riberas Family
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 3:50PM CST
ArcelorMittal (MT) has sold its 35% stake in Spain-based Gestamp Automocion to the majority shareholder, the Riberas family, for a total cash consideration of ???875 million (roughly $980 million).
AEM: 52.28 (+0.15), AKS: 4.30 (unch), MT: 5.56 (+0.11)
ArcelorMittal's Q4 Loss Narrower than Expected, Sales Beat
Zacks Equity Research - Zacks Investment Research - Mon Feb 08, 10:06AM CST
Steel giant ArcelorMittal (MT) posted a net loss of $6.7 billion or $3.72 per share in fourth-quarter 2015, compared with a net loss of $711 million or 40 cents per share recorded a year ago.
AEM: 52.28 (+0.15), AKS: 4.30 (unch), MT: 5.56 (+0.11)
e Research on Progressive Care, Stevia Corp, Titan Medical, and Usinas Siderurgicas de Minas Gerais
ACCESSWIRE - Fri Jan 15, 9:03AM CST
NEW YORK, NY / ACCESSWIRE / January 15, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Progressive Care Inc. (OTC: RXMD), Stevia Corp (OTC: STEV), Titan Medical Inc. (OTC: TITXF) and Usinas Siderurgicas de Minas Gerais SA Usiminas (OTC: USNZY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.